The Patent Vitality Report (PVR) gives patent owners, buyers, and sellers an objective analysis of the assets in a patent portfolio. It provides valuable patent analysis in five understandable scores: overall strength, litigation risk, monetization potential, new technology value, and patent quality. Analyze global patents and applications across critical dimensions. Explore by overall score, litigation risk, monetization potential, new technology value, patent quality, and citation and classification trends.
The Patent Vitality Report (PVR) gives patent owners, buyers, and sellers an objective analysis of the assets in a patent portfolio. It provides valuable patent analysis in five understandable scores: overall strength, litigation risk, monetization potential, new technology value, and patent quality. The PVR, powered by T7 Authority Analysis (IP5 + WIPO + Germany), offers near-global coverage utilizing Gist® and the comprehensive and in-depth analysis required for research.
It’s generated using advanced linguistics, a powerful cognitive search engine, and a statistical process to qualitatively analyze both patent application publications and granted patents from the top 7 (T7) authorities: IP5 + WIPO + Germany.
The PVR is ideal for IP counsel, portfolio owners, and C-suite executives who desire a deep look into their patents’ validity. Our AI-powered report allows these individuals to understand the relative significance of a patent better when compared to other patents, as well as the competitive landscape in a particular technology area.
Advantages of PVR
Discover the full potential of your patents through a comprehensive evaluation of innovation and risk with the Patent Vitality Report. This report applies statistical quality scoring to aid your organization in reevaluating its approach to patent valuation and validity, and making more informed business decisions.
Gain Insight
into the value of patent portfolios before renewing, buying, or selling, giving you better decision-making power.
Compete
more effectively by uncovering patents within our database from global competitors and their subsidiaries and identifying technology investment trends.
Measure
your patent against others with normalized and statistically validated Vitality Scores.
Accelerate
critical decision-making. Get the innovation intelligence your business needs to make informed decisions about your intellectual property with our powerful trio of reporting services.
Inform
licensing, R&D, and renewal decisions. Patent valuation can fluctuate dramatically as technology, litigation, consumer behavior, and other factors shift. While there is no simple way to predict the value of a patent, it is a crucial component to consider within your IP strategy.
Ready to get started?
Download a Patent vitality Report Sample
Fill out the form and we will be in touch shortly.
Patent News & Resources
Get a Preview of Exciting New Features in the IP Suite at AI Masters 2024
Explore AI at IP Watchdog AI Masters 2024! Join the event for discussions on AI and ML. As proud sponsors, we’ll be showcasing innovations from March 4-6, 2024, in Ashburn, Virginia. Connect with us, preview exclusive features, and dive into the future of AI in intellectual property.
How the New USPTO Pre-Application Assessment Program Only Reinforces the Need for Integrated & Intelligent Patent Evaluation Software
With a steady increase in patent submission rate and added strain on the patent review and approval system, the USPTO has announced plans to launch a new pre-application review program called the “Pre-Prosecution Pilot” as part of its continuing commitment to expand access to the innovation ecosystem and support under resourced inventors.
How Apple, the Largest Company in the World, Plays the Patent Infringement Gamble
In recent news, Apple has faced a patent infringement suit regarding the blood oxygen technology in two of its Apple Watch Series models resulting in a halt in sales of their watch models. The halt in sales comes after the International Trade Commission ruled that these two models’ use of blood oxygen tracking violated a patent from health technology company Masimo.